BIOTECH THAWS OUT

BIOTECH THAWS OUT: “Small drug discovery firms are capitalizing on the positive momentum that’s returned to the market for biotechnology stocks. A dozen have announced plans this quarter to launch initial public stock offerings (IPOs), while nearly as many more hope to raise money through follow-on bids. The upturn, if it persists, may help rescue […]


Venter Announces $500K Prize for Significant Advances Toward $1,000 Genome

Venter Announces $500K Prize for Significant Advances Toward $1,000 Genome “Just before lunch today at the GSAC conference, Craig Venter stood before the crowd and announced a mouth-watering proposition: a $500,000 Genomic Technology Prize to be awarded by the J. Craig Venter Science Foundation to a person or organization that develops technology ‘to significantly advance’ […]


The Odd Couple – CombinatoRx brings matchmaking to drug discovery and development

The Odd Couple – CombinatoRx brings matchmaking to drug discovery and development While almost everyone in the drug industry is looking for ways to speed new drugs to market, CombinatoRx has taken a particularly pragmatic approach: Rather than looking for new drugs, it is searching for novel combinations of existing drugs with synergistic effects.